Status:
COMPLETED
EXIT: Prospective Study of the Response to Exercise
Lead Sponsor:
University of Manitoba
Conditions:
Liver Fat
Type 2 Diabetes
Eligibility:
All Genders
12-18 years
Brief Summary
Background : Regular exercise is a cornerstone in the prevention and the management of comorbidities. Unfortunately, the metabolic benefit of exercise training is not universal and varies among indiv...
Eligibility Criteria
Inclusion
- Adolescents (12-18 years)
- Body mass index considered obese according to the International Obesity Task Force
Exclusion
- Adolescents with medication-induced or type 1 diabetes
- are currently being treated with corticosteroids or atypical antipsychotics, as these agents significantly influence carbohydrate metabolism
- have an orthopaedic injury or chronic illness that would prevent them from performing the intervention
- have experienced \>10% weight loss or enrolled in weight loss program within six months of enrolment
- a history of alcoholism or drug abuse
- require use of medication(s) known to affect insulin sensitivity or secretion within the last 30 days
- medication(s) known to cause weight gain
- anabolic steroids
- weight loss medication(s)
- pregnant or planning to be pregnant
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02204670
Start Date
July 1 2014
End Date
October 1 2015
Last Update
March 31 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Manitoba Institute of Child Health
Winnipeg, Canada